Creo Medical Group PLC (LON:CREO – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 21 ($0.27) and last traded at GBX 21.42 ($0.28), with a volume of 538148 shares traded. The stock had previously closed at GBX 22.35 ($0.29).
Creo Medical Group Stock Performance
The company has a debt-to-equity ratio of 29.96, a current ratio of 3.24 and a quick ratio of 2.19. The stock has a market capitalization of £75.43 million, a P/E ratio of -347.50 and a beta of 0.86. The company has a 50 day simple moving average of GBX 26.98 and a 200-day simple moving average of GBX 31.64.
Creo Medical Group Company Profile
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Featured Articles
- Five stocks we like better than Creo Medical Group
- Airline Stocks – Top Airline Stocks to Buy Now
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Overbought Stocks Explained: Should You Trade Them?
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
